Javier Munoz, MD, MS, FACP
Advertisement
Articles by Javier Munoz, MD, MS, FACP
Javier Munoz, MD, MS, FACP, of the Mayo Clinic, considers the appropriateness for CAR T-cell therapy for a 66-year-old woman with relapsed/refractory mantle cell lymphoma.
Advertisement
Latest Updated Articles
Mantle Cell Lymphoma: Overview and Standard of CareAugust 28th 2020
R/R MCL: Treating With CAR-TAugust 28th 2020
Rationale for CAR-T to Treat R/R MCLAugust 28th 2020
Case Overview: 66-Year-Old Woman With MCLAugust 28th 2020
Next Steps in Research in R/R MCLAugust 28th 2020
R/R MCL: Applying Data Into Clinical PracticeAugust 28th 2020
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
NCCN Survey Finds Persistent Cancer Drug Shortages Across US Centers
2
Risk-Adapted Quadruplet Therapy Sustains 5-Year Survival Benefit in High-Risk Myeloma
3
FDA Grants Final Approval to Cabozantinib Capsule Formulation
4
Subcostal Robotic Surgery Cuts Thoracic Pain
5